Biography
Scott Megill is President and CEO of Coriell Life Sciences (CLS). With a vision to translate decades of cutting-edge genetic research into insights that empower the most precise medical care, Scott launched CLS out of the renowned Coriell Institute for Medical Research in 2013. Under his leadership, CLS has grown to become an internationally trusted provider of comprehensive medication risk management solutions, bioinformatics, and genetic interpretation and reporting services. Pioneering innovation in precision medicine, Scott is a driving force in setting the industry standard for pharmacogenomics and advancing a healthier world. An entrepreneurial leader recognized for unlocking the power of technology to fuel smarter healthcare, Scott spearheads collaboration with major healthcare providers, payers, employers, and physicians, to help improve lives and reduce healthcare costs. He is passionate about educating others and is an advocate for the advancement of precision medici43ne through his involvement with industry and professional organizations.